DNB Aktiv 80 A vs UBS Lux Equity Fund Biotech USD

DNB Aktiv 80 A vs UBS Lux Equity Fund Biotech USD

1. DNB Aktiv 80 A

  • Security

    DNB Aktiv 80 A

  • Fee

    1.04%

  • ISIN

    NO0010337793

  • Holdings

    1

2. UBS Lux Equity Fund Biotech USD

  • Security

    UBS Lux Equity Fund Biotech USD P-acc

  • Fee

    2.25%

  • ISIN

    LU0069152568

  • Holdings

    9

Fund Holdings

We have information about 1 holdings in DNB Aktiv 80 A, where the largest holding is DNB Teknologi (11.85), followed by (0) and (0). In comparison with UBS Lux Equity Fund Biotech USD, we have 11 holdings where Regeneron Pharmaceuticals is the largest holding (10.04), followed by Moderna (9.21) and Vertex (8.44).

All Holdings

Here we compare the holdings in DNB Aktiv 80 A and UBS Lux Equity Fund Biotech USD.

DNB Aktiv 80 A UBS Lux Equity Fund Biotech USD
1. DNB Teknologi A
11.85 %
1. Regeneron Pharmaceuticals Inc
10.04 %
- 2. Moderna Inc
9.21 %
- 3. Vertex Pharmaceuticals Inc
8.44 %
- 4. Alnylam Pharmaceuticals Inc
8.08 %
- 5. AbbVie Inc
USA
4.91 %
- 6. Gilead Sciences Inc
USA
4.66 %
- 7. Amgen Inc
USA
4.43 %
- 8. BioNTech SE
4.13 %
- 9. Karuna Therapeutics Inc
3.75 %

The list of fund holdings was last updated on July 27, 2025.